Applied Molecular Transport Inc.
AMTINASDAQHealthcare
$0.26
$-0.01(-3.13%)
Market Cap$11006287
P/E Ratio—
52W High$0.84
52W Low$0.1343
Applied Molecular Transport Inc. (AMTI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
AMTI · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 9, 2023EPS Actual
-$0.17
Est. -$0.50 · +66.0%
Revenue
—
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 9, 2023
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
AMTI reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q4 FY2023 | Nov 9, 2023 | -$0.50 | -$0.17 | +66.0% | — | — | — |
| ▼ Q3 FY2023 | Aug 14, 2023 | $0.77 | -$0.44 | -157.1% | — | — | — |
| ▼ Q2 FY2023 | May 11, 2023 | -$0.61 | -$0.71 | -16.4% | — | — | — |
| ▲ Q1 FY2023 | Mar 9, 2023 | -$0.66 | -$0.58 | +12.1% | — | — | — |
| ▲ Q4 FY2022 | Nov 7, 2022 | -$0.66 | -$0.65 | +1.5% | — | — | — |
| ▼ Q3 FY2022 | Aug 4, 2022 | -$0.65 | -$0.93 | -43.1% | — | — | — |
| ▼ Q2 FY2022 | May 9, 2022 | -$0.70 | -$1.10 | -57.1% | — | — | — |
| ▼ Q1 FY2022 | Feb 24, 2022 | -$0.63 | -$0.78 | -23.8% | — | — | — |
Q4 FY2023
Nov 9, 2023Beat
EPS Actual
-$0.17
EPS Est.
-$0.50
EPS Surpr.
+66.0%
Revenue
—
Q3 FY2023
Aug 14, 2023Miss
EPS Actual
-$0.44
EPS Est.
$0.77
EPS Surpr.
-157.1%
Revenue
—
Q2 FY2023
May 11, 2023Miss
EPS Actual
-$0.71
EPS Est.
-$0.61
EPS Surpr.
-16.4%
Revenue
—
Q1 FY2023
Mar 9, 2023Beat
EPS Actual
-$0.58
EPS Est.
-$0.66
EPS Surpr.
+12.1%
Revenue
—
Q4 FY2022
Nov 7, 2022Beat
EPS Actual
-$0.65
EPS Est.
-$0.66
EPS Surpr.
+1.5%
Revenue
—
Q3 FY2022
Aug 4, 2022Miss
EPS Actual
-$0.93
EPS Est.
-$0.65
EPS Surpr.
-43.1%
Revenue
—
Q2 FY2022
May 9, 2022Miss
EPS Actual
-$1.10
EPS Est.
-$0.70
EPS Surpr.
-57.1%
Revenue
—
Q1 FY2022
Feb 24, 2022Miss
EPS Actual
-$0.78
EPS Est.
-$0.63
EPS Surpr.
-23.8%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 0 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 0 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 0 |
| Q4 FY2023 | $-0.51 | $-0.51 | $-0.51 | 1 |
| Q3 FY2023 | $-0.50 | $-0.50 | $-0.50 | 1 |
| Q2 FY2023 | $0.77 | $0.77 | $0.77 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2023 | Nov 9, 2023 | +66.0% | $0.19 | $0.17 | -6.49% |
| ▼ Q3 FY2023 | Aug 14, 2023 | -157.1% | $0.28 | $0.29 | +5.40% |
| ▼ Q2 FY2023 | May 11, 2023 | -16.4% | $0.28 | $0.28 | -1.06% |
| ▲ Q1 FY2023 | Mar 9, 2023 | +12.1% | $0.64 | $0.57 | -10.22% |
| ▲ Q4 FY2022 | Nov 7, 2022 | +1.5% | $0.86 | $0.92 | +6.98% |
| ▼ Q3 FY2022 | Aug 4, 2022 | -43.1% | $1.86 | $1.93 | +3.76% |
| ▼ Q2 FY2022 | May 9, 2022 | -57.1% | $4.45 | $4.37 | -1.80% |
| ▼ Q1 FY2022 | Feb 24, 2022 | -23.8% | $6.23 | $6.73 | +8.03% |
Q4 FY2023-6.49%
Report Date
Nov 9, 2023
EPS Beat/Miss
+66.0%
Price Before
$0.19
Price After
$0.17
Q3 FY2023+5.40%
Report Date
Aug 14, 2023
EPS Beat/Miss
-157.1%
Price Before
$0.28
Price After
$0.29
Q2 FY2023-1.06%
Report Date
May 11, 2023
EPS Beat/Miss
-16.4%
Price Before
$0.28
Price After
$0.28
Q1 FY2023-10.22%
Report Date
Mar 9, 2023
EPS Beat/Miss
+12.1%
Price Before
$0.64
Price After
$0.57
Q4 FY2022+6.98%
Report Date
Nov 7, 2022
EPS Beat/Miss
+1.5%
Price Before
$0.86
Price After
$0.92
Q3 FY2022+3.76%
Report Date
Aug 4, 2022
EPS Beat/Miss
-43.1%
Price Before
$1.86
Price After
$1.93
Q2 FY2022-1.80%
Report Date
May 9, 2022
EPS Beat/Miss
-57.1%
Price Before
$4.45
Price After
$4.37
Q1 FY2022+8.03%
Report Date
Feb 24, 2022
EPS Beat/Miss
-23.8%
Price Before
$6.23
Price After
$6.73
Avg Beat Reaction-3.24%
Avg Miss Reaction+2.87%
Beat Rate3 / 8 quarters
Largest Move-10.22% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: AMTI ends December
Applied Molecular Transport Inc. (AMTI) most recently reported earnings on November 9, 2023 for Q4 FY2023, posting EPS of $-0.17 — beating the analyst consensus of $-0.50 by +66.0%. The next AMTI earnings date is expected around September 1, 2026.
Each quarter, investors track AMTI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. AMTI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
AMTI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
AMTI earnings · 5 questionsApplied Molecular Transport Inc.'s next earnings report is expected around September 1, 2026. AMTI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; AMTI historically reports after market close (AMC).
AMTI earnings datewhen is AMTI earningsAMTI next earnings datewhen does AMTI report earningsAMTI earnings calendar
▸ Source: FMP · Applied Molecular Transport Inc. SEC filings · US GAAP · Applied Molecular Transport Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026